Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes

dc.contributor.authorMcGuire, DK
dc.contributor.authorNewby, LK
dc.contributor.authorBhapkar, MV
dc.contributor.authorMoliterno, DJ
dc.contributor.authorHochman, JS
dc.contributor.authorKlein, WW
dc.contributor.authorWeaver, WD
dc.contributor.authorPfisterer, M
dc.contributor.authorCorbalan, R
dc.contributor.authorDellborg, M
dc.contributor.authorGranger, CB
dc.contributor.authorVan de Werf, F
dc.contributor.authorTopol, EJ
dc.contributor.authorCaliff, RM
dc.contributor.authorSYMPHONY and 2nd SYMPHONY Investigators
dc.date.accessioned2024-01-10T12:37:42Z
dc.date.available2024-01-10T12:37:42Z
dc.date.issued2004
dc.description.abstractBackground Diabetes is associated with an increased risk for coronary artery disease (CAD) and its complications. The relative effect of glucose-lowering strategies of "insulin provision" versus "insulin sensitization" among patients with CAD remains unclear.
dc.description.abstractMethods To evaluate the associations of diabetes and hypoglycemic strategies with clinical outcomes after acute coronary syndromes, we analyzed data from 15,800 patients enrolled in the SYMPHONY and 2nd SYMPHONY trials.
dc.description.abstractResults Compared with nondiabetic patients, patients with diabetes (n = 3101; 19.6%) were older, more often female, more often had prior CAD, hypertension, and hyperlipidemia, and less often were current smokers. The diabetic cohort had, higher 90-day unadjusted risk of the composite of death/myocardial infarction (MI)/severe recurrent ischemia (SRI), death/MI, and death alone, as well as a near doubling of 1-year mortality rates. At 1 year, diabetes was associated with significantly higher adjusted risks of death/MI/SRI (OR, 1.3 [95% confidence interval, 1.1, 1.5]) and death/MI (OR, 1.2 [1.0, 1.4]). Hypoglycemic therapy including only insulin and/or sulfonylurea (insulin-providing; n = 1473) was associated with higher 90-day death/MI/SRI compared with therapy that included only biguanide and/or thiazolidinedione therapy (insulin-sensitizing; n = 100) (12.0% vs 5.0%); (adjusted OR, 2.1 [1.2, 3.7]).
dc.description.abstractConclusions Diabetic patients with acute coronary syndromes had worse clinical outcomes. Although the findings regarding the influence of glycemic-control strategies should be interpreted with caution because of the exploratory nature of the analyses and the relatively small sample size of the insulin-sensitizing group, the improved risk-adjusted outcomes associated with insulin-sensitizing therapy underscore the need to further evaluate treatment strategies for patients with diabetes and CAD.
dc.fechaingreso.objetodigital2024-03-19
dc.format.extent7 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.ahj.2003.07.024
dc.identifier.issn0002-8703
dc.identifier.pubmedidMEDLINE:14760321
dc.identifier.urihttps://doi.org/10.1016/j.ahj.2003.07.024
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/76904
dc.identifier.wosidWOS:000220253900014
dc.information.autorucMedicina;Corbalán R;S/I;98700
dc.issue.numero2
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final252
dc.pagina.inicio246
dc.publisherMOSBY, INC
dc.revistaAMERICAN HEART JOURNAL
dc.rightsacceso restringido
dc.subjectACUTE MYOCARDIAL-INFARCTION
dc.subjectRANDOMIZED-TRIAL
dc.subjectCARDIOVASCULAR EVENTS
dc.subjectHYPOGLYCEMIC AGENTS
dc.subjectMORTALITY
dc.subjectSIBRAFIBAN
dc.subjectASPIRIN
dc.subjectINSULIN
dc.subjectCOMPLICATIONS
dc.subjectPREVENTION
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAssociation of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
dc.typeartículo
dc.volumen147
sipa.codpersvinculados98700
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024-03-19. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.pdf
Size:
129.45 KB
Format:
Adobe Portable Document Format
Description: